Reply to Lassaunière: On the functional characterization of the Y453F RBD variant found in cluster 5 SARS-CoV-2.

Bayarri-Olmos, Rafael; Johnsen, Laust Bruun; Rosbjerg, Anne; Helgstrand, Charlotte; Bak-Thomsen, Theresa; Garred, Peter; Skjoedt, Mikkel-Ole

Bayarri-Olmos, Rafael; Johnsen, Laust Bruun; Rosbjerg, Anne; Helgstrand, Charlotte; Bak-Thomsen, Theresa; Garred, Peter; Skjoedt, Mikkel-Ole.

Afiliação

Bayarri-Olmos R; Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark.
Johnsen LB; Novo Nordisk A/S, Måløv, Denmark.
Rosbjerg A; Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark; Institute of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
Helgstrand C; Novo Nordisk A/S, Måløv, Denmark.
Bak-Thomsen T; Novo Nordisk A/S, Måløv, Denmark.
Garred P; Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark.
Skjoedt MO; Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark; Institute of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark. Electronic address: moskjoedt@sund.ku.dk.

J Biol Chem ; 297(5): 101241, 2021 11.

Article em En | MEDLINE | ID: mdl-34735911

Assuntos

COVID-19; SARS-CoV-2; Anticorpos Neutralizantes; Humanos; Glicoproteína da Espícula de Coronavírus

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Revista: J Biol Chem Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Dinamarca

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google